(UroToday.com) In the World Urological Oncology Federation (WUOF) Symposium held in conjunction with this year’s virtual Société Internationale d’Urologie (SIU) annual congress, Dr. Seth Lerner presented on an assessment of proteomics in predicting response to neoadjuvant chemotherapy in urothelial carcinoma.